CannaPharmaRX, Inc. (CPMD)
| Market Cap | 2.89M |
| Revenue (ttm) | 820.14K |
| Net Income (ttm) | -9.91M |
| Shares Out | 656.27M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 38,561 |
| Open | 0.0040 |
| Previous Close | 0.0044 |
| Day's Range | 0.0040 - 0.0044 |
| 52-Week Range | 0.0001 - 0.0176 |
| Beta | -1,525.90 |
| RSI | 40.71 |
| Earnings Date | May 14, 2025 |
About CannaPharmaRX
CannaPharmaRX, Inc. evaluates, negotiates, acquires, and develops various cannabis cultivation projects in Canada. The company is based in Calgary, Canada. [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy
CALGARY, AB / ACCESSWIRE / December 3, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cannabis cultivation, is steadily advancing its position in high-efficiency cannabis production. T...
CannapharmaRx to Complete Additional Shipment in November
CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at i...
CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
CALGARY, AB / ACCESSWIRE / August 15, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received t...
Q1 2024 Financial Results
CannaPharmaRx Announces Q1 2024 Financial Results Showcasing Commencement of Revenue CALGARY, AB / ACCESSWIRE / June 28, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, hig...
CannapharmaRx Pays Off Convertible Notes
CALGARY, AB / ACCESSWIRE / April 2, 2024 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has extinguished...
CannapharmaRx Receives First Purchase Order and Begins Shipment of Product
CannapharmaRx products have been approved for sale in multiple countries worldwide CALGARY, AB / ACCESSWIRE / March 14, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, high...
CannaPharmaRx Completes First Harvests
CALGARY, AB / ACCESSWIRE / March 12, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has completed i...
CannaPharmaRx to Hold Investor Conference Call
CALGARY, AB / ACCESSWIRE / March 7, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an inv...
CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas
CALGARY, AB / ACCESSWIRE / March 5, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that the company finaliz...
CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration
CALGARY, AB / ACCESSWIRE / February 23, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that the company has...
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
CALGARY, AB / ACCESSWIRE / February 16, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has entered ...
CannaPharmaRx CEO Provides Annual Update Message
CALGARY, AB / ACCESSWIRE / February 15, 2024 / Cannapharmarx, Inc. Dear Fellow Shareholders, We are paving the way for a remarkable year capitalizing on the solid foundation achieved last year. 2023 w...
CannaPharmaRx Expands Board of Directors
CALGARY, AB / ACCESSWIRE / August 25, 2023 / CannaPharmaRx, Inc. (OTC EXPERT:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has expanded...
CannaPharmaRx Appoints Dean Medwid as New CEO
CALGARY, AB / ACCESSWIRE / June 23, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that the company has app...
CannaPharmaRx Signs Agreement with Nasha Genetics
CALGARY, AB / ACCESSWIRE / April 19, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a Me...
CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
CALGARY, AB / ACCESSWIRE / March 30, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a Su...
CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
CALGARY, AB / ACCESSWIRE / March 21, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has finalized t...
CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
CALGARY, AB / ACCESSWIRE / February 21, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a...
CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
CALGARY, AB / ACCESSWIRE / February 1, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that its Board of Dir...
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
CALGARY, AB / ACCESSWIRE / January 30, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities today released a letter from its Chie...
CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
CALGARY, AB / ACCESSWIRE / January 11, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received ...
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 22, 2022) - Investorideas.com, a leading investor news resource covering cannabis and wellness stocks releases a special on ...
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- CannaPharmaRx, Inc. (OTC PINK:CPMD)(the “Company”), an emerging leader in development and operation of ultramodern, highly efficie...
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
CALGARY, AB / ACCESSWIRE / December 21, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD) (the "Company"), an emerging leader in development and operation of ultramodern, highly efficient cannabis grow facil...
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio
CALGARY, AB / ACCESSWIRE / December 19, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it has secured new g...